Gene therapy could improve Alzheimer’s disease

Tuesday 25 September 2018 PDF Print

Introducing healthy genes into missing or damaged cells could help cure degenerative diseases like Alzheimer’s and Huntington’s, according to new research from Université Paris-Saclay.

The researchers injected mice with an enzyme that is missing in Alzheimer’s and Huntington's sufferers.

They discovered this enzyme is critically important as it is responsible for the regulation of cholesterol in the brain.

“The regulation of cholesterol is important for the regulation of signals between brain cells (neurons). We have found if you give mice more of the enzyme that regulates cholesterol, you can improve the signals between neurons and therefore improve the symptoms of Alzheimer’s or Huntington’s disease.” Says Dr Nathalie Cartier.

The researchers are now preparing the first therapeutic trial of the drug to patients suffering with Huntington’s disease. If this is a success, the same approach could be used to treat Alzheimer’s disease.

It is a huge step for the treatment of severe neurodegenerative diseases.
/ENDS

For more information, a copy of the paper, or to speak to Dr Nathalie Carter contact Kate Mowbray at BlueSky PR on kate@bluesky-pr.com or call +44 (0)1582 790 957

This press release was distributed by ResponseSource Press Release Wire on behalf of BlueSky Public Relations Ltd in the following categories: Health, Education & Human Resources, Medical & Pharmaceutical, for more information visit https://pressreleasewire.responsesource.com/about.

Release from
Follow Newsroom
  • Established in 2002, BlueSky is the specialist in PR and communications for recruitment, HR, talent management and other niche sectors. Our team concentrates on securing quality coverage in trade, broadsheet and international media as well as ...
  • hello@bluesky-pr.com
  • https://www.bluesky-pr.com/recruitment-hr-talent-management
  • 01582 790700
020 3426 4051

© 1997-2025 ResponseSource Ltd